Cardiac Arrhythmia Signal Analysis (CASA) Laboratory

Dr. Damian Redfearn - New England Journal of Medicine NEJM

Published Fri May 13th 2016

The Department extends congratulations to Dr. Damian Redfearn as coauthor on an important NEJM paper! 

"The multi centre randomized clinical trial has shown that catheter ablation for recurrent ventricular tachycardia is both safe and effective, moreover in patients with VT despite anti arrhythmia drugs it is superior to escalating drug therapy in both prevention  of recurrent VT and complications." - Dr. Damian Redfearn

Tags: